Schlecht, G. et al. Murine plasmacytoid dendritic cells induce effector/memory CD8+ T-cell responses in vivo after viral stimulation. Blood 104, 1808−1815

Unité de Biologie des Régulations Immunitaires, Institut National de la Santé et de la Recherche Médicale, Institut Pasteur, 25 rue du Docteur Roux, 75724 Paris cedex 15, France.
Blood (Impact Factor: 10.43). 10/2004; 104(6):1808-15. DOI: 10.1182/blood-2004-02-0426
Source: PubMed

ABSTRACT Like their human counterparts, mouse plasmacytoid dendritic cells (pDCs) play a central role in innate immunity against viral infections, but their capacity to prime T cells in vivo remains unknown. We show here that virus-activated pDCs differentiate into antigen-presenting cells able to induce effector/memory CD8(+) T-cell responses in vivo against both epitopic peptides and endogenous antigen, whereas pDCs activated by synthetic oligodeoxynucleotides containing unmethylated cytosine-guanine motifs (CpG) acquire only the ability to recall antigen-experienced T-cell responses. We also show that immature pDCs are unable to induce effector or regulatory CD8(+) T-cell responses. Thus, murine pDCs take part in both innate and adaptive immune responses by directly priming naive CD8(+) T cells during viral infection.

Download full-text


Available from: Antonio A Freitas, Jul 29, 2015
  • Source
    • "The remarkably functional diversity of the DC system relies on the plasticity and complexity of the DC differentiation process, which leads to the generation of a large collection of DC subpopulations, endowed with specific functions. DCs can be classified in two major categories: conventional DCs (Mayordomo et al., 1997; Steinman et al., 1997) and pDCs (O'Keeffe et al., 2002; Schlecht et al., 2004), characterized by their capacity to produce large amounts of type I IFNs during viral infections (Kadowaki et al., 2000). It has been demonstrated that scrapie-infected DCs intravenously injected can propagate prions (Huang et al., 2002). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Transmissible spongiform encephalopathies (TSEs) or prion diseases develop as central nervous system (CNS) disorders characterized by extremely long incubation periods. Although TSEs do not go along with inflammatory infiltrates and/or antibody production against the prion protein (PrP(Sc)), the immune system plays an important role in pathogenesis as long as different lymphoid organs (Peyer's patches, lymph nodes and spleen) may facilitate the accumulation and further spread of prions after peripheral exposure. In this work we investigated the changes in lymphoid and dendritic cell (DC) populations as well as the implications of different cytokines during disease progression after experimental oral inoculation of prions in a transgenic mouse model. At different days post-inoculation (dpi), T and B lymphocytes and DC populations from lymphoid organs, blood and brain were analyzed by flow cytometry and immunohistochemistry. Besides time related variations in lymphoid cell numbers due to the aging of the animals significant changes related with the infection were found in mesenteric lymph nodes, peripheral blood leukocytes (PBLs) as well as in spleen, affecting the CD4/CD8 ratio. In contrast, little or no variation was detected in Peyer's Patches or in thymus either associated with aging or the infection status. At individual time points significant differences between infected and control mice were seen in the CD8, CD4 and DC populations, with less evidence of differences in the B cell compartment. Finally, a pro-inflammatory phenotype occurred at early times in the spleen, where the levels of lymphotoxin-beta mRNA were found augmented with respect to controls. Altogether, these results suggest that normal regulation of lymphocyte populations becomes altered along the progression of a prion infection.
    Veterinary Immunology and Immunopathology 05/2008; 122(3-4):204-15. DOI:10.1016/j.vetimm.2007.11.013 · 1.75 Impact Factor
  • Source
    • "Soluble, endotoxin-free OVA is a weak stimulator for CD8 + , CD4 + T cell and antibody responses, but becomes strongly immunogenic when IAV is administered 2–3 days prior to OVA (Brimnes et al., 2003). Similarly, peptide-loaded pDCs prime CD8 + T cells in vivo when they are stimulated by IAV, and not by CpG (Schlecht et al., 2004). Intercurrent IAV infection in mice sensitized intranasally to OVA either breaks immunological tolerance when it is administered simultaneously to OVA, or induces Th1-mediated protection when it is administered later (van Rijt et al., 2005). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Crosspresentation is a specialized function of myeloid dendritic cells (mDCs), allowing them to induce CD8+ T cell responses against exogenous antigens that are not directly produced in their cytotosol. Human plasmacytoid DCs (pDCs) are not considered so far as able to perform crosspresentation. We showed here that purified human pDCs crosspresented vaccinal lipopeptides and HIV-1 antigens from apoptotic cells to specific CD8+ T lymphocytes. Apoptotic debris were internalized by phagocytosis and the lipopeptide LPPol reached nonacidic endosomes. This crosspresentation was amplified upon influenza virus infection. Importantly, the efficiency of crosspresentation by pDCs was comparable to that of mDCs. This property of human pDCs needs to be taken into account to understand the pathogenesis of infectious, allergic, or autimmune diseases and to help achieve desired responses during vaccination by targeting specifically either type of DCs.
    Immunity 10/2007; 27(3):481-92. DOI:10.1016/j.immuni.2007.07.021 · 19.75 Impact Factor
  • Source
    • "One possibility is that VV can mature DC of a different type, such as plasmacytoid DC. However, although these DC have been shown to produce copious amounts of IFNα/β that may promote maturation of neighboring DC; their ability to prime naïve T cells in vivo remains controversial (Facchetti et al., 1988; Siegal et al., 1999; Nakano et al., 2001; Asselin-Paturel et al., 2001; Krug et al., 2003; Schlecht et al., 2004). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Understanding how vaccinia virus (VV) generates immunity necessitates an appreciation for how this virus interacts with dendritic cells (DC), which are the most potent activators of naïve CD8(+) T cells. In order to optimally activate naïve CD8(+) T cells, DC must undergo maturation, during which costimulatory molecules are upregulated and cytokines are produced. In this report, we show that VV infection of immature murine bone marrow-derived DC (BMDC) failed to induce maturation. Similar results were obtained when CD8(+) DC were analyzed, a subset shown previously to be important in vivo in the generation of a vaccinia-specific response. The finding that VV infection of DC resulted in APC that were incapable of initiating T-cell activation was surprising given the previously reported role for direct presentation in the generation of anti-VV CD8(+) T-cell responses in mice. To address the potential mechanism responsible for direct presentation, we tested the hypothesis that previously matured DC were susceptible to vaccinia virus infection and could present newly synthesized VV-derived epitopes for CD8(+) T-cell activation. Our results show, that during VV infection of mature DC, threshold levels of viral protein are produced that promote T-cell activation. These results suggest that, even though VV cannot mature DC, previously matured DC exposed to VV can generate a VV-specific CD8(+) T-cell response providing a potential mechanism by which direct infection results in T-cell activation in vivo.
    Virology 04/2007; 359(2):349-61. DOI:10.1016/j.virol.2006.09.020 · 3.28 Impact Factor
Show more